Cost effectiveness of cardiovascular therapies hugely variable Clinical study 30 January 2013 Pages: 1 - 1
Little evidence for benefits with direct-to-consumer advertising Non-clinical study 30 January 2013 Pages: 2 - 2
WHO guidelines for kids with pneumonia ± HIV-1 inadequate Clinical study 30 January 2013 Pages: 5 - 5
Authorised generic pharmaceuticals reduce the price and increase the availability of generic medicines, Media release 30 January 2013 Pages: 5 - 5
Telbivudine good value for patients with chronic hepatitis B Clinical study 30 January 2013 Pages: 6 - 6
Many patients who are receiving twice-daily lansoprazole for gastro-oesophageal reflux disease (GERD) can be switched to once-daily rabeprazole, Clinical study 30 January 2013 Pages: 7 - 7
β-blockers continue to be prescribed as first-line therapy in elderly patients Epidemiology clinical study 30 January 2013 Pages: 7 - 7
Adherence-improving strategy cost effective for hypertension? Clinical study 30 January 2013 Pages: 8 - 8
Dextranomer/hyaluronan injection improves QOL in kids with VUR Clinical study 30 January 2013 Pages: 9 - 9
WHO recommendations to establish a stockpile of vaccine against H5N1 influenza virus have received support from vaccine manufacturers, News item 30 January 2013 Pages: 10 - 10
The UK Labour government is welcoming reports from NHS clinical directors as an indication of improvements News item 30 January 2013 Pages: 10 - 10
Growing use of biologicals for immunologic disease in the US News item 30 January 2013 Pages: 10 - 10
The introduction of a generic version of sanofi-aventis' Ambien [zolpidem] will enable “multi-million dollar savings” Media release 30 January 2013 Pages: 10 - 10
Access to healthcare and certain key health indicators have improved in Afghanistan Clinical study 30 January 2013 Pages: 11 - 11
Bayer HealthCare is supporting the WHO in its attempt to eradicate Chagas' disease from Latin America. Media release 30 January 2013 Pages: 11 - 11